Purpose

In this study the investigators will evaluate a new point of care Quantra Hemostasis Analyzer system to assess coagulation rapidly with ease.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 55 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Pregnant woman at 37-41 weeks gestation

Exclusion Criteria

  • Hypertension
  • Preeclampsia
  • Gestational diabetes
  • Preexisting coagulopathy
  • History of deep vein thrombosis (DVT)
  • Medications that impair coagulation
  • History of pulmonary embolism or thrombosis
  • Women in active labor receiving intravenous fluids or oxytocin

Study Design

Phase
N/A
Study Type
Interventional
Intervention Model
Single Group Assignment
Primary Purpose
Basic Science
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Other
Pregnant Women
All subjects will have the same intervention. Samples will be taken and manipulated in the laboratory for use of the Hemosonic Qauntra Analyzer
  • Device: Quantra Analyzer
    Subjects blood will be manipulated in the lab and will be tested with the Quantra Analyzer

Recruiting Locations

University of Maryland Baltimore
Baltimore, Maryland 21201

More Details

Status
Recruiting
Sponsor
University of Maryland, Baltimore

Study Contact

Bhavani Kodali, MD
410-328-4229
bkodali@som.umaryland.edu

Detailed Description

Unexpected bleeding continues to be an issue that confronts anesthesiologists. Obstetric bleeding spearheads as the leading cause of maternal mortality and morbidity. One of the hurdles that clinicians confront is a lack of point of care coagulation system that can hasten the clinical management strategy in the right direction. Conventional methods take considerable time to obtain results. TEG and ROTEM are currently doing the job however these two modalities requires expertise and proficient training to perform test and interpret results. The level of expertise to run the TEG and ROTEM poses hurdles for providing coagulation around the clock as it requires trained operators. What is currently required for efficient and effective management of obstetric hemorrhage is a point of care coagulation system in the operating room and or labor and delivery suite that is user friendly, easy and quick to perform. In this study the investigators will evaluate a new point of care Quantra Hemostasis Analyzer system to assess coagulation rapidly with ease.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.